Relations of insulin sensitivity to longitudinal blood pressure tracking: variations with baseline age, body mass index, and blood pressure
Clinicians must take into account mechanisms of action, level of HbA1c reduction, impact on fasting plasma glucose and/or post-prandial glucose levels, safety and tolerability, effects on weight, route of administration, and finally, cost
However, there is no established causal link between tirzepatide and the development of hypertension, and the preponderance of evidence suggests a beneficial effect on blood pressure control
However, critics worry that moving peptides like BPC-157 into legitimate pharmacies could make people think they've been proven safe and effective, when the data behind them is still limited
Beck RW, Bergenstal RM (2021) Beyond A1C-standardization of continuous glucose monitoring reporting: why it is needed and how it continues to evolve
It was about the equivalent of a dash of salt you would sprinkle over a fish on a frying pan, concentrated in a tiny bottle
